MX2015013175A - Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas. - Google Patents
Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas.Info
- Publication number
- MX2015013175A MX2015013175A MX2015013175A MX2015013175A MX2015013175A MX 2015013175 A MX2015013175 A MX 2015013175A MX 2015013175 A MX2015013175 A MX 2015013175A MX 2015013175 A MX2015013175 A MX 2015013175A MX 2015013175 A MX2015013175 A MX 2015013175A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- hyperproliferative diseases
- coumarin derivatives
- treating hyperproliferative
- fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan compuestos derivados de cumarina y métodos para el tratamiento de enfermedades hiperproliferativas, tales como cáncer, enfermedad renal poliquistica y fibrosis de diferentes tejidos (por ejemplo, fibrosis pulmonar idiopática) Los métodos incluyen administrarle a un sujeto un compuesto tal como se describe en la presente. También se proporcionan métodos para inhibir la interacción entre dos o más proteínas chaperonas de choque térmico en una célula.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361788398P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/027154 WO2014152278A2 (en) | 2013-03-15 | 2014-03-14 | Coumarin derivatives and methods of use in treating hyperproliferative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015013175A true MX2015013175A (es) | 2016-04-04 |
Family
ID=51581693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013175A MX2015013175A (es) | 2013-03-15 | 2014-03-14 | Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US10369145B2 (es) |
EP (1) | EP2970249A4 (es) |
JP (1) | JP6407955B2 (es) |
KR (1) | KR20150132483A (es) |
CN (1) | CN105246887B (es) |
AU (1) | AU2014240003B2 (es) |
CA (1) | CA2903107C (es) |
HK (1) | HK1218537A1 (es) |
MX (1) | MX2015013175A (es) |
WO (1) | WO2014152278A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9221840B2 (en) | 2011-05-17 | 2015-12-29 | Discoverybiomed Inc. | Treating protein folding disorders with small molecule CFTR correctors |
AU2013348019A1 (en) | 2012-11-20 | 2015-06-04 | Discoverybiomed, Inc. | Small molecule bicyclic and tricyclic CFTR correctors |
EP2922852A4 (en) | 2012-11-20 | 2016-05-25 | Discoverybiomed Inc | CFTR SMALL MOLECULE CORRECTIVES |
JP6514680B2 (ja) | 2013-03-15 | 2019-05-15 | ディスカバリーバイオメッド, インコーポレイテッド | クマリン誘導体、ならびに嚢胞性線維症、慢性閉塞性肺疾患、及びミスフォールドタンパク質障害の治療における使用方法 |
MX2015013175A (es) | 2013-03-15 | 2016-04-04 | Discoverybiomed Inc | Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas. |
CN105541852B (zh) * | 2016-01-29 | 2017-09-15 | 扬州大学 | 2‑(香豆素‑3‑基)‑6‑甲基吡啶并[5,4‑c]香豆素的合成方法 |
CN107098895B (zh) * | 2016-02-19 | 2020-01-07 | 湖南大学 | 苯氨基噻唑甲基喹啉酮衍生物及其制备方法与应用 |
JP2020525446A (ja) * | 2017-06-21 | 2020-08-27 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 常染色体優性多発性嚢胞腎疾患を治療するための嚢胞性線維症膜貫通コンダクタンス制御因子の調節因子 |
CN109464440A (zh) * | 2019-01-17 | 2019-03-15 | 北京大学 | 3-乙酰氨基香豆素在制备治疗或预防肾脏纤维化及慢性肾病的药物中的应用 |
CN112274517A (zh) * | 2020-10-30 | 2021-01-29 | 江苏大学 | 一种治疗套细胞淋巴瘤的药物组合物 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5566580A (en) | 1978-11-11 | 1980-05-20 | Kaken Pharmaceut Co Ltd | Coumarin derivative, its preparation and antiallergic agent containing the same as effective component |
DE10133665A1 (de) | 2001-07-11 | 2003-01-30 | Boehringer Ingelheim Pharma | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
US20030055263A1 (en) | 2001-07-11 | 2003-03-20 | Boehringer Ingelheim Pharma Kg | Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
US6822097B1 (en) * | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
WO2003105842A1 (en) * | 2002-06-13 | 2003-12-24 | Novuspharma S.P.A. | Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
CN101076703A (zh) | 2004-10-13 | 2007-11-21 | Ptc医疗公司 | 用于无义抑制的化合物及其使用方法 |
KR20070084067A (ko) * | 2004-10-13 | 2007-08-24 | 와이어쓰 | N-벤젠설포닐 치환 아닐리노-피리미딘 동족체 |
MX2007004484A (es) * | 2004-10-13 | 2007-06-25 | Ptc Therapeutics Inc | Compuestos de pirazol o triazol y su uso para la fabricacion de un medicamento para tratar las enfermedades relacionadas con la mutacion somatica. |
CN101351208A (zh) | 2005-11-01 | 2009-01-21 | 康乃尔研究基金会有限公司 | 减少细胞胆固醇水平和/或治疗或预防磷脂质病 |
US20090012148A1 (en) * | 2005-11-01 | 2009-01-08 | Maxfield Frederick R | Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
JP2011507811A (ja) | 2007-12-13 | 2011-03-10 | インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション | 哺乳動物のs−ニトロソグルタチオンレダクターゼを阻害するための材料および方法 |
US20120100609A1 (en) | 2009-03-27 | 2012-04-26 | Crawford Brett E | N-linked glycan biosynthesis modulators |
ITMI20111068A1 (it) | 2011-06-14 | 2012-12-15 | Azienda Ospedaliera Universitaria I Ntegrata Di Ve | Trimetilangelicina come correttore di cftr in cellule dell'epitelio bronchiale |
MX2015013175A (es) | 2013-03-15 | 2016-04-04 | Discoverybiomed Inc | Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas. |
JP6514680B2 (ja) * | 2013-03-15 | 2019-05-15 | ディスカバリーバイオメッド, インコーポレイテッド | クマリン誘導体、ならびに嚢胞性線維症、慢性閉塞性肺疾患、及びミスフォールドタンパク質障害の治療における使用方法 |
-
2014
- 2014-03-14 MX MX2015013175A patent/MX2015013175A/es unknown
- 2014-03-14 CN CN201480015013.4A patent/CN105246887B/zh active Active
- 2014-03-14 KR KR1020157029644A patent/KR20150132483A/ko not_active Application Discontinuation
- 2014-03-14 US US14/775,050 patent/US10369145B2/en active Active
- 2014-03-14 AU AU2014240003A patent/AU2014240003B2/en active Active
- 2014-03-14 CA CA2903107A patent/CA2903107C/en active Active
- 2014-03-14 WO PCT/US2014/027154 patent/WO2014152278A2/en active Application Filing
- 2014-03-14 EP EP14768111.8A patent/EP2970249A4/en active Pending
- 2014-03-14 JP JP2016502351A patent/JP6407955B2/ja active Active
-
2016
- 2016-06-07 HK HK16106496.8A patent/HK1218537A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP6407955B2 (ja) | 2018-10-17 |
CN105246887B (zh) | 2018-05-11 |
KR20150132483A (ko) | 2015-11-25 |
JP2016513685A (ja) | 2016-05-16 |
HK1218537A1 (zh) | 2017-02-24 |
WO2014152278A3 (en) | 2014-11-13 |
US10369145B2 (en) | 2019-08-06 |
AU2014240003A1 (en) | 2015-09-03 |
WO2014152278A2 (en) | 2014-09-25 |
CA2903107A1 (en) | 2014-09-25 |
CN105246887A (zh) | 2016-01-13 |
EP2970249A4 (en) | 2017-03-15 |
EP2970249A2 (en) | 2016-01-20 |
AU2014240003B2 (en) | 2017-12-14 |
CA2903107C (en) | 2021-11-02 |
US20160038475A1 (en) | 2016-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015013175A (es) | Derivados de cumarina y metodos de uso en el tratamiento de enfermedades hiperproliferativas. | |
MX2020010496A (es) | Inhibidores de desmetilasa-1 especifica de lisina. | |
WO2015168466A8 (en) | Inhibitors of lysine specific demethylase-1 | |
MX2014005928A (es) | Inhibidores ciclicos de glutaminasa. | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
MX2016002544A (es) | Compuestos utiles como inmunomoduladores. | |
MX343706B (es) | Derivados heterocíclicos novedosos. | |
IN2015DN02573A (es) | ||
UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
WO2012118812A3 (en) | Substituted 6,5-fused bicyclic heteroaryl compounds | |
EA201490418A1 (ru) | Новые макроциклические соединения в качестве ингибиторов фактора xia | |
MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
MX2015005963A (es) | Inhibidores heterociclicos de glutaminasa. | |
MX349004B (es) | Nuevos compuestos. | |
MX362215B (es) | Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1. | |
MX368903B (es) | Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas. | |
EA201690386A1 (ru) | Соединения и композиции в качестве ингибиторов mek | |
MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
MX2016004114A (es) | Derivados de 1,4-dihidrodioxina fusionada como inhibidores del factor de trascripcion de choque termico 1. | |
WO2013040227A3 (en) | Therapeutic compounds | |
EA201591024A1 (ru) | Димерные соединения | |
MX2014003376A (es) | Derivados de acido benzoico como inhibidores eif4e. | |
WO2016004404A3 (en) | Gls1 inhibitors for treating disease |